This prospective , case-controlled study examined 57 eyes ( 57 patients ) with ME secondary to CRVO , which were treated with IVR ( 0.5 mg , n = 30 eyes ) or IVR ( 0.5 mg ) and IVTA ( 1mg , n = 27eyes ) as the initial therapy .